EPISODE #76 Standardisation and Medical Cannabis with Oliver Zugel, CEO at Foliumed The Cannabis Conversation | Medical Cannabis | CBD | Hemp

Why is standardisation so important for medical cannabis?


This week we’re joined by Oliver Zugel, CEO and Founder of Foliumed - international producers of pharmaceutical grade cannabis, operating between Colombia and Germany.


Together, we explore standardisation of cannabis as a medical product, including Good Manufacturing Practices (GMP), the challenges of standardising flower, and the market trend towards using extracts within medical applications.

→ View full show notes and summary here: https://www.cannabis-conversation.com/blogs/episode76

About Oliver
Oliver Zugel is the founder and CEO of Foliumed, a medical cannabis producer with operations  in Germany and Colombia. Foliumed focuses on non-smokable, pharmaceutical product forms which permit precise dosing. Its ingredients are sourced from its organic farm in the Colombian highlands, and processed in a German EU-GMP certified facility. 

Quotables
People overestimate the current size of the medical market outside of North America 04:15
Standardisation is an absolute must in all circumstances 08:42

Resources

Join on LinkedIn: https://www.linkedin.com/in/oliverzugel/
Foliumed Website: www.foliumed.com